J P Furia1. 1. Orthopedic Consultant, Bucknell University, SUN Orthopedics and Sports Medicine, Lewisburg. jfuria@sunortho.com
Abstract
PURPOSE: The purpose of this study was to determine the efficacy of extracorporeal shock wave therapy (ESWT) for the treatment of adults with chronic insertional Achilles tendinopathy. METHODS: 68 patients with chronic insertional Achilles tendinopathy were enrolled in this study. A total of 35 patients were treated with a single dose of ESWT (3000 shocks of 0.20 mJ/mm(2), ESWT group), while 33 patients were treated with traditional non-operative measures (control group). RESULTS: At 3 months post treatment, the mean VAS for the control and ESWT groups were 2.9 and 7.2 respectively. Using the Roles and Maudsley scale, 39% of the control patients and 51% of the ESWT patients were assigned an excellent or good result. CONCLUSIONS: ESWT as applied is a safe and effective treatment for chronic insertional Achilles tendinopathy.
PURPOSE: The purpose of this study was to determine the efficacy of extracorporeal shock wave therapy (ESWT) for the treatment of adults with chronic insertional Achilles tendinopathy. METHODS: 68 patients with chronic insertional Achilles tendinopathy were enrolled in this study. A total of 35 patients were treated with a single dose of ESWT (3000 shocks of 0.20 mJ/mm(2), ESWT group), while 33 patients were treated with traditional non-operative measures (control group). RESULTS: At 3 months post treatment, the mean VAS for the control and ESWT groups were 2.9 and 7.2 respectively. Using the Roles and Maudsley scale, 39% of the control patients and 51% of the ESWT patients were assigned an excellent or good result. CONCLUSIONS: ESWT as applied is a safe and effective treatment for chronic insertional Achilles tendinopathy.
Authors: S Ohtori; G Inoue; C Mannoji; T Saisu; K Takahashi; S Mitsuhashi; Y Wada; K Takahashi; M Yamagata; H Moriya Journal: Neurosci Lett Date: 2001-11-23 Impact factor: 3.046
Authors: John A Ogden; Richard G Alvarez; Richard L Levitt; Jeffrey E Johnson; Marie E Marlow Journal: J Bone Joint Surg Am Date: 2004-10 Impact factor: 5.284
Authors: Ludger Gerdesmeyer; Stefan Wagenpfeil; Michael Haake; Markus Maier; Markus Loew; Klaus Wörtler; Renee Lampe; Romain Seil; Gerhart Handle; Susanne Gassel; Jan D Rompe Journal: JAMA Date: 2003-11-19 Impact factor: 56.272
Authors: J I Wiegerinck; G M Kerkhoffs; M N van Sterkenburg; I N Sierevelt; C N van Dijk Journal: Knee Surg Sports Traumatol Arthrosc Date: 2012-10-06 Impact factor: 4.342
Authors: Robert M Barker-Davies; Alastair Nicol; I McCurdie; James Watson; Polly Baker; Patrick Wheeler; Daniel Fong; Mark Lewis; Alexander N Bennett Journal: BMC Musculoskelet Disord Date: 2017-05-22 Impact factor: 2.362
Authors: Nacime Salomão Barbachan Mansur; Flávio Faloppa; João Carlos Belloti; Sheila J McNeill Ingham; Fabio Teruo Matsunaga; Paulo Roberto Dias Dos Santos; Bruno Schiefer Dos Santos; Oreste Lemos Carrazzone; Gabriel Peixoto; Bruno Takeshi Aoyama; Marcel Jun Sugawara Tamaoki Journal: BMJ Open Date: 2017-01-27 Impact factor: 2.692